Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Commonwealth Bank of Australia (ASX: CBA) shares are a popular option for investors.

It isn't hard to see why this is the case.

Australia's largest bank is widely regarded as one of the highest quality banks in the world.

In addition, CBA shares have a strong track record of delivering outsized returns for investors.

But right now, according to The Bull, experts think investors should be taking profit and putting their money into a beaten down exchange traded fund (ETF).

Let's see what it is recommending.

A man looking at his laptop and thinking.

Image source: Getty Images

Sell CBA shares

Sanlam Private Wealth fears that higher interest rates could impact credit growth for CBA.

And given its premium valuation, it thinks this could make it a good time to reduce exposure to the bank. It explains:

The bank is a quality company and a staple in investor portfolios. It has established a strong track record of performance over many years. The company delivered a 5 per cent increase in statutory net profit after tax in the first half of fiscal year 2026. However, the dividend yield was trading below 3 per cent on March 26, so better income is available elsewhere.

The conflict in Iran suggests a possibly slowing global economy likely to impact credit growth in Australia's higher interest rate environment. CBA is trading at a premium to peers, so it may be time to consider reducing exposure in this volatile environment.

Buy this ASX ETF

Catapult Wealth is very positive on the BetaShares S&P/ASX Australian Technology ETF (ASX: ATEC) after a heavy share price decline.

This week, the wealth management firm named the tech-focused fund as a buy. It thinks artificial intelligence (AI) disruption fears are overdone, explaining:

This exchange traded fund invests in Australian technology companies. ATEC has experienced a material pullback alongside the broader Australian technology sector, creating an attractive entry point for long term investors. Share prices in several of its key constituents, including Xero, WiseTech Global, Pro Medicus and REA Group, have fallen significantly despite stable earnings trajectories and ongoing revenue growth across the sector.

Market concerns surrounding artificial intelligence disruption appear overdone, in my view, particularly given the high costs of switching software platforms. Despite weaker sentiment, fundamentals are largely intact. In our view, an appealing opportunity exists to gain exposure to high quality Australian technology names through ATEC.

Motley Fool contributor James Mickleboro has positions in Pro Medicus, REA Group, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Happy shareholders clap and smile as they listen to a company earnings report.
Broker Notes

Morgans says these ASX shares could rise 12% to 20%

Let's see what the broker is recommending to clients this week.

Read more »

Broker looking at the share price.
Broker Notes

Buy, hold, sell: James Hardie, TechnologyOne, and Webjet shares

Let's see what analysts at Morgans are saying about these shares.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Temple & Webster and James Hardie shares

A leading analyst expects James Hardie and Temple & Webster shares to continue to underperform. But why?

Read more »

Man sits smiling at a computer showing graphs.
Broker Notes

Why Morgans upgraded this ASX 200 share and downgraded another

The broker has updated its ratings on these shares.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

3 ASX shares Morgans rates as buys this week

Let's see what the broker is recommending to clients.

Read more »

a group of tech people gather around a computer operated by a young woman while the group looks on in support.
Broker Notes

Does Bell Potter think TechnologyOne shares are a buy?

Here's what the broker is saying about this popular stock after its results.

Read more »

A young man wearing a backpack in a city street crosses his fingers and hopes for the best.
Broker Notes

5 ASX shares with 50% to 60% upside ahead: Experts

Brokers are optimistic on these stocks.

Read more »